Bennet, Tillis, Sinema, Paul, 15 Colleagues Call on FDA to Rely on Scientific Evidence for MDMA-Assisted Therapy to Treat Post-Traumatic Stress Disorder
August 05, 2024
August 05, 2024
WASHINGTON, Aug. 5 -- Sen. Michael F. Bennet, D-Colorado, issued the following news release:
Denver U.S. Senators Michael Bennet (D-Colo.), Thom Tillis (R-N.C.), Kyrsten Sinema (I-Ariz.), and Rand Paul (R-Ky.), alongside 15 of their Senate colleagues, urged U.S. Food and Drug Administration (FDA) Commissioner Robert Califf to remain firmly anchored in scientific evidence and data as the FDA considers approval of MDMA-Assisted Therapy (MDMA-AT) to treat Post-Traumatic Stress Disorder . . .
Denver U.S. Senators Michael Bennet (D-Colo.), Thom Tillis (R-N.C.), Kyrsten Sinema (I-Ariz.), and Rand Paul (R-Ky.), alongside 15 of their Senate colleagues, urged U.S. Food and Drug Administration (FDA) Commissioner Robert Califf to remain firmly anchored in scientific evidence and data as the FDA considers approval of MDMA-Assisted Therapy (MDMA-AT) to treat Post-Traumatic Stress Disorder . . .